Evaluation of Albumin Platelet Product for Fibrosis Detection in MASLD

A retrospective cohort study of 570 patients with either metabolic dysfunction-associated steatotic liver disease (MASLD) or metabolic dysfunction-associated steatohepatitis (MASH) has found that a novel blood-based biomarker, albumin platelet…

Continue Reading